Literature DB >> 16986107

Precision in measurements of perfusion and microvascular permeability with T1-weighted dynamic contrast-enhanced MRI.

Lucy E Kershaw1, David L Buckley.   

Abstract

Dynamic contrast-enhanced MRI is used to estimate microvascular parameters by tracer kinetics analysis. The time for the contrast agent to travel from the artery to the tissue of interest (bolus arrival time (BAT)) is an important parameter that must be measured in such studies because inaccurate estimates or neglect of BAT contribute to inaccuracy in model fitting. Furthermore, although the precision with which these parameters are estimated is very important, it is rarely reported. To address these issues, two investigations were undertaken. First, simulated data were used to validate an independent method for estimation of BAT. Second, the adiabatic approximation to the tissue homogeneity model was fitted to experimental data acquired in prostate and muscle tissue of 22 patients with prostate cancer. A bootstrap error analysis was performed to estimate the precision of parameter estimates. The independent method of estimating BAT was found to be more accurate and precise than a model-fitting approach. Estimated precisions for parameters measured in the prostate gland were 14% for extraction fraction (median coefficient of variation), 19% for blood flow, 28% for permeability-surface area product, 35% for volume of the extravascular-extracellular space, and 36% for blood volume. Techniques to further reduce uncertainty are discussed. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16986107     DOI: 10.1002/mrm.21040

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  18 in total

1.  Response of HT29 colorectal xenograft model to cediranib assessed with 18 F-fluoromisonidazole positron emission tomography, dynamic contrast-enhanced and diffusion-weighted MRI.

Authors:  Louisa Bokacheva; Khushali Kotedia; Megan Reese; Sally-Ann Ricketts; Jane Halliday; Carl H Le; Jason A Koutcher; Sean Carlin
Journal:  NMR Biomed       Date:  2012-07-08       Impact factor: 4.044

Review 2.  Dynamic contrast-enhanced magnetic resonance imaging and pharmacokinetic models in prostate cancer.

Authors:  Tobias Franiel; Bernd Hamm; Hedvig Hricak
Journal:  Eur Radiol       Date:  2010-12-24       Impact factor: 5.315

3.  Uncertainty and bias in contrast concentration measurements using spoiled gradient echo pulse sequences.

Authors:  Matthias C Schabel; Dennis L Parker
Journal:  Phys Med Biol       Date:  2008-04-17       Impact factor: 3.609

4.  Evaluation of the effect of transcytolemmal water exchange analysis for therapeutic response assessment using DCE-MRI: a comparison study.

Authors:  Chunhao Wang; Ergys Subashi; Xiao Liang; Fang-Fang Yin; Zheng Chang
Journal:  Phys Med Biol       Date:  2016-06-08       Impact factor: 3.609

5.  A model-constrained Monte Carlo method for blind arterial input function estimation in dynamic contrast-enhanced MRI: II. In vivo results.

Authors:  Matthias C Schabel; Edward V R DiBella; Randy L Jensen; Karen L Salzman
Journal:  Phys Med Biol       Date:  2010-08-03       Impact factor: 3.609

6.  A model-constrained Monte Carlo method for blind arterial input function estimation in dynamic contrast-enhanced MRI: I. Simulations.

Authors:  Matthias C Schabel; Jacob U Fluckiger; Edward V R DiBella
Journal:  Phys Med Biol       Date:  2010-08-03       Impact factor: 3.609

Review 7.  Tracer-kinetic modeling of dynamic contrast-enhanced MRI and CT: a primer.

Authors:  Michael Ingrisch; Steven Sourbron
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-04-06       Impact factor: 2.745

8.  An analysis of the uncertainty and bias in DCE-MRI measurements using the spoiled gradient-recalled echo pulse sequence.

Authors:  Ergys Subashi; Kingshuk R Choudhury; G Allan Johnson
Journal:  Med Phys       Date:  2014-03       Impact factor: 4.071

9.  Robust and efficient pharmacokinetic parameter non-linear least squares estimation for dynamic contrast enhanced MRI of the prostate.

Authors:  Soudabeh Kargar; Eric A Borisch; Adam T Froemming; Akira Kawashima; Lance A Mynderse; Eric G Stinson; Joshua D Trzasko; Stephen J Riederer
Journal:  Magn Reson Imaging       Date:  2017-12-24       Impact factor: 2.546

10.  Accelerated Brain DCE-MRI Using Iterative Reconstruction With Total Generalized Variation Penalty for Quantitative Pharmacokinetic Analysis: A Feasibility Study.

Authors:  Chunhao Wang; Fang-Fang Yin; John P Kirkpatrick; Zheng Chang
Journal:  Technol Cancer Res Treat       Date:  2016-05-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.